Human embryonic stem cell (hESC) therapy is the potential therapeutic option for the treatment of patients with aplastic anemia (AA). The study showed a remarkable improvement in the AA patient subsequent to hESC administration. No adverse events occurred in the patient. hESC therapy is safe and effective for AA patients.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5458044 | PMC |
http://dx.doi.org/10.1002/ccr3.950 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!